v3.26.1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders’ Equity [Abstract]  
Schedule of Outstanding and Exercisable Warrants

As of June 30, 2026, the following table summarizes the status of our outstanding and exercisable warrants and related transactions since December 31, 2025 (in thousands, except weighted average exercise price and weighted average remaining contractual life data):

 

    Warrants outstanding and exercisable  
    Warrants     Weighted
Average
Exercise
Price
    Aggregate
Intrinsic
Value
    Weighted
Average
Remaining
Contractual
Life
(in Years)
 
Balance, as of December 31, 2025     98     $ 63.33     $        -       4.6  
Balance, as of June 30, 2026     98     $ 63.33     $ -       4.1  
Schedule of Outstanding and Exercisable Options

The following table summarizes the status of our outstanding and exercisable options and related transactions since December 31, 2025 (in thousands, except weighted average exercise price and weighted average remaining contractual life data):

 

    Outstanding     Exercisable  
    Options
Awards
    Weighted
Average
Exercise
Price
    Aggregate
Intrinsic
Value
    Weighted
Average
Remaining
Contractual
Life
(in Years)
    Options
Awards
    Weighted
Average
Exercise
Price
    Aggregate
Intrinsic
Value
    Weighted Average Remaining Contractual Life (in Years)  
Balance, as of December 31, 2025     105     $ 74.05     $       7.3       105     $ 74.04     $       7.3  
Balance, as of June 30, 2026     105     $ 73.18     $       6.8       105     $ 73.17     $       6.8  
Schedule of RSUs and Related Transactions

The following table summarizes the status of our RSUs and related transactions since December 31, 2025 (in thousands, except weighted average grant date fair value):

 

    RSUs awards outstanding  
    RSUs     Weighted
Average
Grant Date
Fair Value
    Aggregate
Intrinsic
Value
 
Balance, as of December 31, 2025     26     $ 1.15     $ 41.57  
Balance, as of June 30, 2026     26     $ 1.15     $ 56.36